Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gamma-aminobutyric acid A receptor alpha-2 subunit (GABRA2) is a protein encoded by the GABRA2 gene in humans. It forms part of the GABA-A receptor, which is a ligand-gated chloride channel activated by gamma-aminobutyric acid (GABA), the major inhibitory neurotransmitter in the mammalian brain. The GABA-A receptors are pentameric complexes typically composed of two alpha, two beta, and one gamma subunit; GABRA2 represents one of six possible alpha subunits. Activation by GABA leads to hyperpolarization of neuronal membranes, inhibiting neuronal firing. GABRA2 plays key roles in emotional regulation and behavioral control and has been linked to conditions such as alcoholism, anxiety disorders, and epilepsy.
Positive allosteric modulation of GABA-A receptor, leading to increased chloride ion conductance and neuronal hyperpolarization.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid A receptor alpha-2 subunit (GABRA2).